Skip to main content
TipRanks
Go Ultimate75% OFF

Medtronic (2M6) Stock Statistics & Valuation Metrics

9 Followers

Total Valuation

Medtronic has a market cap or net worth of EUR 117.29B. The enterprise value is EUR 129.69B.

Market Cap
EUR 117.29B
Enterprise Value
EUR 129.69B

Share Statistics

Medtronic has 1,279,169,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
1,279,169,900
Owned by Insiders
0.07%
Owned by Institutions
77.65%

Financial Efficiency

Medtronic’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.13%.

Return on Equity (ROE)
0.10
Return on Assets (ROA)
0.05
Return on Invested Capital (ROIC)
6.13%
Return on Capital Employed (ROCE)
0.08
Revenue Per Employee
382.78K
Profits Per Employee
50.53K
Employee Count
95,000
Asset Turnover
0.39
Inventory Turnover
2.14

Valuation Ratios

The current PE Ratio of Medtronic is 24.50. Medtronic’s PEG ratio is 1.98.

PE Ratio
24.50
PS Ratio
3.41
PB Ratio
2.55
Price to FCF
20.85
Price to Operating Cash Flow
15.92
PEG Ratio
1.98

Income Statement

In the last 12 months, Medtronic had revenue of 36.36B and earned 4.80B in profits. Earnings per share was 3.75.

Revenue
36.36B
Gross Profit
23.64B
Operating Income
6.47B
Pretax Income
6.14B
Net Income
4.80B
EBITDA
9.81B
Earnings Per Share (EPS)
3.75

Cash Flow

In the last 12 months, operating cash flow was 8.04B and capital expenditures -1.90B, giving a free cash flow of 6.13B billion.

Operating Cash Flow
8.04B
Free Cash Flow
6.13B
Free Cash Flow per Share
4.79

Dividends & Yields

Medtronic pays an annual dividend of EUR 0.63, resulting in a dividend yield of 2.70%

Dividend Per Share
EUR 0.63
Dividend Yield
2.70%
Payout Ratio
50.75%
Free Cash Flow Yield
4.81%
Earnings Yield
4.10%

Stock Price Statistics

Beta
0.30
52-Week Price Change
6.69%
50-Day Moving Average
83.56
200-Day Moving Average
75.49
Relative Strength Index (RSI)
64.60
Average Volume (3m)
1,625

Important Dates

Medtronic upcoming earnings date is Nov 24, 2026, Before Open (Not Confirmed).

Last Earnings Date
Sep 01, 2026
Next Earnings Date
Nov 24, 2026
Ex-Dividend Date
Jun 26, 2026

Financial Position

Medtronic as a current ratio of 2.13, with Debt / Equity ratio of 56.53%

Current Ratio
2.13
Quick Ratio
1.62
Debt to Market Cap
0.26
Net Debt to EBITDA
2.65
Interest Coverage Ratio
9.04

Taxes

In the past 12 months, Medtronic has paid 1.30B in taxes.

Income Tax
1.30B
Effective Tax Rate
0.21

Enterprise Valuation

Medtronic EV to EBITDA ratio is 14.99, with an EV/FCF ratio of 25.09.

EV to Sales
4.10
EV to EBITDA
14.99
EV to Free Cash Flow
25.09
EV to Operating Cash Flow
19.15

Balance Sheet

Medtronic has EUR 8.82B in cash and marketable securities with EUR 28.15B in debt, giving a net cash position of -EUR 19.33B billion.

Cash & Marketable Securities
EUR 8.82B
Total Debt
EUR 28.15B
Net Cash
-EUR 19.33B
Net Cash Per Share
-EUR 15.11
Tangible Book Value Per Share
-EUR 2.01

Margins

Gross margin is 66.69%, with operating margin of 18.08%, and net profit margin of 13.93%.

Gross Margin
66.69%
Operating Margin
18.08%
Pretax Margin
17.59%
Net Profit Margin
13.93%
EBITDA Margin
27.35%
EBIT Margin
19.52%

Analyst Forecast

The average price target for Medtronic is EUR 97.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
EUR 97.75
Price Target Upside
5.75% Upside
Analyst Consensus
Moderate Buy
Analyst Count
20
Revenue Growth Forecast
3.13%
EPS Growth Forecast
5.28%

Scores

Smart Score
10
AI Score
―